Measurement of lipoprotein (a) is now recommended in several patient subgroups for whom excess lipoprotein (a) may have important clinical consequences: (1) patients with premature atherosclerosis, (2) patients with a strong family history of premature coronary heart disease (CHD), (3) patients with elevated LDLC and greater than or equal to two risk factors, (4) patients who have had coronary angioplasty in whom lipoprotein (a) excess may increase the risk of restenosis, and (5) patients who have undergone coronary bypass graft surgery in whom Lp(a) excess may be associated with graft stenosis.

Elevated concentrations of Lp(a) are associated with increased risk of coronary artery disease.

A significant deviation from the normal range may require further evaluation by your physician.

Alternative Name(s): Lp (a), Lipoprotein Little a, Lp Little a